stoxline Quote Chart Rank Option Currency Glossary
  
Inspire Medical Systems, Inc. (INSP)
187.01  3.02 (1.64%)    02-12 16:00
Open: 182.38
High: 191
Volume: 464,782
  
Pre. Close: 183.99
Low: 181.945
Market Cap: 5,604(M)
Technical analysis
2025-02-12 4:45:42 PM
Short term     
Mid term     
Targets 6-month :  231.2 1-year :  252.29
Resists First :  197.94 Second :  216
Pivot price 188.54
Supports First :  168.72 Second :  140.38
MAs MA(5) :  183.08 MA(20) :  186.5
MA(100) :  194.01 MA(250) :  187.02
MACD MACD :  -1.2 Signal :  -0.6
%K %D K(14,3) :  34.3 D(3) :  28.8
RSI RSI(14): 49.1
52-week High :  257.39 Low :  123
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ INSP ] has closed above bottom band by 42.3%. Bollinger Bands are 26.4% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 191.25 - 192.02 192.02 - 192.76
Low: 180.07 - 180.91 180.91 - 181.7
Close: 185.66 - 186.98 186.98 - 188.24
Company Description

Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient's breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.

Headline News

Wed, 12 Feb 2025
Truist Financial Has Lowered Expectations for Inspire Medical Systems (NYSE:INSP) Stock Price - MarketBeat

Tue, 11 Feb 2025
Inspire Medical Systems Inc (INSP) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance

Mon, 10 Feb 2025
Inspire Medical more than doubles bottom line on 25% sales growth in Q4 - Mass Device

Mon, 10 Feb 2025
Inspire (INSP) Reports Q4 Earnings: What Key Metrics Have to Say - Yahoo Finance

Mon, 10 Feb 2025
Inspire Medical Systems (INSP) Q4 Earnings and Revenues Surpass Estimates - Yahoo Finance

Mon, 10 Feb 2025
Inspire Medical Systems Inc. (INSP) reports earnings - Quartz

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Underperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Underperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Outperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Outperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
NYSE
Sector:
Healthcare
Industry:
Medical - Devices
Shares Out 30 (M)
Shares Float 29 (M)
Held by Insiders 1.9 (%)
Held by Institutions 115.1 (%)
Shares Short 2,280 (K)
Shares Short P.Month 2,320 (K)
Stock Financials
EPS 1.1
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 23.25
Profit Margin 4.3 %
Operating Margin 7 %
Return on Assets (ttm) 1.1 %
Return on Equity (ttm) 5.3 %
Qtrly Rev. Growth 32.5 %
Gross Profit (p.s.) 21.37
Sales Per Share 25.21
EBITDA (p.s.) 0.61
Qtrly Earnings Growth 0 %
Operating Cash Flow 78 (M)
Levered Free Cash Flow 21 (M)
Stock Valuations
PE Ratio 170
PEG Ratio 0
Price to Book value 8.04
Price to Sales 7.41
Price to Cash Flow 71.55
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android